If a patient’s own blood is reinfused during major lifesaving cancer surgery, can modern technology reduce the risks of infection and cancer dissemination.
Not Applicable
- Conditions
- intraoperative cell salvagepelvic exenteration surgerycolorectal cancer surgeryAnaesthesiology - AnaestheticsCancer - Bowel - Back passage (rectum) or large bowel (colon)Blood - Other blood disordersSurgery - Other surgery
- Registration Number
- ACTRN12624000167561
- Lead Sponsor
- Royal Brisbane and Women's Hosptial
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patients with colorectal cancer scheduled for pelvic exenteration surgery
Exclusion Criteria
Patients who decline participation and consent.
Patients who experience <800mL blood loss during surgery.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method